ArticleMedicine2026
Safety and efficacy of ERCP using standard duodenoscopes in pediatric patients with choledocholithiasis: A retrospective study.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to evaluate the safety and efficacy of endoscopic retrograde cholangiopancreatography (ERCP) in children aged 2 to 13 years with choledocholithiasis, addressing the challenges of using standard adult duodenoscopes in a pediatric population. Materials and Methods: We retrospectively reviewed the medical records of 107 patients who underwent ERCP at a single tertiary ERCP center between 2014 and 2024. Among these, patients with chronic pancreatitis or biliary strictures were excluded, resulting in a final cohort of 70 pediatric patients. A control group of 397 adult patients with similar conditions was analyzed for comparison. Procedural success was defined as successful deep cannulation of the common bile duct and stone extraction. The pediatric group achieved a procedural success rate of 91.4%, compared to 95.2% in adults, with no statistically significant difference (P = .278). Complication rates were low and similar between groups: bleeding occurred in 8.6% of pediatric patients, while pancreatitis was noted in 1.4%. No mortalities were reported in the pediatric cohort. The findings indicate that ERCP can be performed safely and effectively in children using standard adult duodenoscopes by experienced adult gastroenterologists under proper supervision. The procedural success rates and complication rates were comparable to adults, suggesting that ERCP is a viable option for pediatric choledocholithiasis. To optimize outcomes, further multicenter studies and improved pediatric training are recommended.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.